about
CADASIL and CARASIL.Early white matter changes in CADASIL: evidence of segmental intramyelinic oedema in a pre-clinical mouse modelPotassium channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a genetic model of small vessel disease.Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASILReducing Timp3 or vitronectin ameliorates disease manifestations in CADASIL mice.Cerebral venous thrombosis in inflammatory bowel diseases: eight cases and literature review.Endovascular management of extracranial occlusions at the hyperacute phase of stroke with tandem occlusions.Visibility of Blood Flow on Optical Coherence Tomography Angiography in a Case of Branch Retinal Artery Occlusion.Differential diagnosis between sarcoidosis and granulomatosis with polyangiitis in a patient with leptomeningeal, cavernous sinus and pituitary lesions.Archetypal Arg169Cys Mutation in NOTCH3 Does Not Drive the Pathogenesis in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leucoencephalopathy via a Loss-of-Function MechanismResponse to Letter Regarding Article, “Archetypal Arg169Cys Mutation in NOTCH3 Does Not Drive the Pathogenesis in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leucoencephalopathy via a Loss-of-Function Mechanism”Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau.What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France.[Severe dysautonomia revealing Wernicke's encephalopathy]Neurosarcoidosis: leptomeninigeal, cavernous sinus and pituitary involvementIncreased PKR level in human CADASIL brains
P50
Q30861866-53C01F34-FEB8-439B-94D5-DE69C4943B7EQ33669397-C6730211-F9B4-479B-8384-548DFC5E93EFQ35128837-F43291E7-B494-439E-AE9E-1A63393EE7BEQ36904906-FDBA2606-8A12-4C41-AB8D-E846773828BAQ37713541-F51F4109-0D6B-4A68-9E7A-F621C8F165AAQ37948174-F685DB6E-7BDD-4ABA-BAF6-925E428076F1Q50044362-DA122206-FEB2-41B2-A3C6-494A9BC56386Q50096608-D9454765-5EA9-4AC4-9250-D3EC638951BFQ50100193-DFECBE37-2C5A-4BF3-843E-281CEBB9606DQ57811225-5C06B65D-218D-4A67-A643-187582CE1F59Q57811238-9DECAD0F-9AD1-4357-AED6-A64B453E8DF3Q64934926-73F01FA1-179A-49A8-975E-203CA5110FF2Q64983497-1A485ED8-0B89-4158-879C-7C3CBDC7FE8FQ85188668-D9FE5679-AFB4-47AC-98E0-80B124D30E12Q89250231-8F798EC3-49CA-4416-B4A9-5556AF98BB97Q90728907-CCDC5614-B5E7-478F-A9E8-BE7C67279DAC
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-3521-5832
@en
name
Emmanuel Cognat
@ast
Emmanuel Cognat
@en
Emmanuel Cognat
@es
Emmanuel Cognat
@nl
type
label
Emmanuel Cognat
@ast
Emmanuel Cognat
@en
Emmanuel Cognat
@es
Emmanuel Cognat
@nl
prefLabel
Emmanuel Cognat
@ast
Emmanuel Cognat
@en
Emmanuel Cognat
@es
Emmanuel Cognat
@nl
P106
P31
P496
0000-0002-3521-5832